Technology

Aravive

$5.80
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.16 (+2.84%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Aravive and other stocks, options, and ETFs commission-free!

About ARAV

Aravive, Inc. Common Stock, also called Aravive, is a clinical-stage biotechnology company, which engages in developing new therapies that target important survival pathways for both advanced solid tumors as well as hematologic malignancies. Its product candidate, Aravive-S6, is a soluble Fc-fusion protein designed to block the activation of the GAS6-AXL signaling pathway by intercepting the binding of GAS6 to its receptor AXL which also promotes metastasis, cancer cell survival, resistance to treatments, and immune suppression. The company was founded on December 10, 2008 and is headquartered in Houston, TX. The listed name for ARAV is Aravive, Inc. Common Stock.

CEO
Gail Frances McIntyre
Employees
17
Headquarters
Houston, Texas
Founded
2008
Market Cap
97.44M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
100.14K
High Today
$5.95
Low Today
$5.54
Open Price
$5.66
Volume
100.04K
52 Week High
$14.94
52 Week Low
$3.34

Collections

ARAV Earnings

-$0.72
-$0.48
-$0.24
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 26, Pre-Market

You May Also Like

PSA-D
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure